Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

Terumo BCT Congratulates Innovative Clinicians With the 2015 Advancing Apheresis Award; Applications Open for 2016


Terumo BCT funds a $10,000 grant to the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Terumo BCT, a global medical device manufacturing company, is pleased to announce Rajendra Chaudhary, MD, Head of the Transfusion Medicine Department at the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India, as the 2015 winner of the Advancing Apheresis Award. The award includes a $10,000 USD grant for clinicians, physicians and operators who are leaders in the practice of therapeutic apheresis and cell collections.

Applications for the 2016 Advancing Apheresis Award: Solving Venous Access Challenges, are now being accepted from apheresis innovators globally. Applications are due by 30 September 2016. Click here to learn more and submit your application.

“Many thanks to Terumo BCT and the grant committee for the 2015 Advancing Apheresis Award,” said Dr. Chaudhary. “The grant provides essential resources to promote apheresis medicine and blood donations and is an example of how contributions to the health care community can accelerate important initiatives.”

Dr. Chaudhary’s project was chosen by an independent committee of top apheresis physicians from around the world and will focus on the creation of a platelet donor registry and the promotion of apheresis through telemedicine. SGPGIMS is a top-tier medical center and the first in India to perform therapeutic plasma exchange.

The 2015 Grant Committee included the following physicians: 

  • Klemens Budde, MD Head of Clinical Transplant, Department of Nephrology, Charité University, Germany
  • Zbigniew Szczepiorkowski, MD, PhD Director, Transfusion Medicine Service & Cellular Therapy Center, Dartmouth-Hitchcock Medical Center; Past President, American Society for Apheresis (ASFA); Lead Contributor to 2010 ASFA Guidelines (U.S.)
  • ZiYi Lim, MBChB, MRCP, FRCPath Senior Consultant, Haematology, Parkway Cancer Center, Singapore
  • Giorgio Baldanzi, MD Medical Director, HEMOBANCO, Brazil

For more information, please visit

About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.

Media Contact
Corporate Communications
Phone: +1.303.205.2599
Contact Us


{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{$index+1}}. {{s.label}}